Similar Stories to Pfizer Ceo Albert Bourla Tests Positive For Covid-19 And Is Experiencing 'very Mild Symptoms' on Bing News

Albert Bourla, CEO of drugmaker Pfizer, has tested positive for Covid-19 and has "very mild symptoms," he said in a tweet on Monday.

Topics:  health   
RELATED ARTICLES
  • no title provided in feed
    Independent presidential candidate Robert F. Kennedy Jr. told The New York Times he experienced a series of health issues in recent years, including an abnormality that he said was caused by a worm that entered his brain and then died. More
  • no title provided in feed
    Americans' mental health issues are not identified and treated as readily as physical symptoms, especially among children - in part due to a shortage of clinicians. "We're looking for ways to integrate mental health into settings where children and families are every day," says Dr. More
  • no title provided in feed
    Mayor Donna Deegan speaks with CNN's Jake Tapper More
  • no title provided in feed
    Rep. Brad Wenstrup speaks with CNN's Jake Tapper More
  • no title provided in feed
    For some who see a therapist, just talking things through isn't enough. Drama therapy allows the patient to relive a moment or play out their biggest fears. More
  • no title provided in feed
    Sen. Mark Kelly joins The Lead More
BING NEWS:
  • Pfizer accused of 'bringing discredit' on pharmaceutical industry and promoting an 'unlicensed' Covid vaccine
    They shared a post from another employee of Pfizer in the US which said: “Our vaccine candidate is 95 percent effective in preventing COVID-19, and 94 per cent effective in people over 65 years old.
    04/8/2024 - 2:35 am | View Link
  • Pfizer Stock 2025 Forecast: Will PFE Go Up Long Term?
    Though this might bring investors little comfort, sector peer Moderna (MRNA) – which also developed a COVID-19 vaccine ... Pfizer’s CEO Albert Bourla said that, along with growing its ...
    02/15/2024 - 7:07 am | View Link
  • Pfizer Facing Profit Drop After Record Year as COVID Vaccine Demand Fades
    Investors will focus on guidance for 2023, with sales set for a sharp decline amid waning demand for COVID-19 vaccines and ... rate of at least 6%. CEO Albert Bourla said at a recent investor ...
    01/26/2023 - 11:01 am | View Link
  • Pfizer bivalent COVID-19 vaccine starts rollout
    The news follows the recent recommendation of the human medicines committee (CHMP) of the European Medicine Agency (EMA) to authorise COVID-19 bivalent ... According to Albert Bourla, chairman ...
    09/5/2022 - 1:00 pm | View Link
  • Pfizer, BioNTech seek US okay for Omicron BA.4/BA.5 booster
    Pfizer and BioNTech have asked the FDA for emergency authorisation of an Omicron-targeted COVID-19 booster vaccine ... said Pfizer chief executive Albert Bourla. The company already has a $3.2 ...
    08/22/2022 - 1:00 pm | View Link
  • More